Finished
Recovery From dNMB Using Different Sugammadex Doses in Elderly Patients Undergoing Robot-assisted Prostatectomy
NCT04854993 · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Updated 25 Jan 2023
- What is being tested
- Sugammadex 6 mg/kg; Sugammadex 4 mg/kg
- For
- Prostate Cancer; Neuromuscular Blockade
- Kind of study
- Tests a treatment or device on volunteers. Phase 3.
- Who can join
- Ages 65 years and older. About 34 people. The full rules are on the registry page.
- Where
- Italy
- When
- Starts or started 13 July 2021, ends 23 Sept 2022. Registered 22 April 2021.
- Results
- None posted yet.
In the researchers' words
The aim of this prospecive randomized study is to evaluate the effects of a dose of sugammadex increased by 50% compared to a standard dose on recovery time from deep neuromuscular block in elderly patients undergoing robot-assisted laparoscopic radical prostatectomy (RALP). Secondary objectives are to evaluate the different extubation time, time to exit from the operating room (OR), lenght of stay in post-anaesthesia care unit (PACU) and safety (hemodynamic parameters and respiratory function).
Sites
- Fondazione Policlinico Universitario A. Gemelli IRCCSRome, Italy